Montreal and Charlotte, NC, May 8, 2019 — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular...
Art Pappas will participate on a panel to discuss exit strategies, the growing role of Pharma venture capital and alternative financing strategies at the 8th annual BioExec Institute Retreat on Friday, March 23 in Miami, Florida.
News | 03. 19. 2012
Art Pappas will participate on a panel to discuss exit strategies, the growing role of Pharma venture capital and alternative financing strategies at the 8th annual BioExec Institute Retreat on Friday, March 23 in Miami, Florida.
